Stocks to Buy

Identifying winning stocks requires more than scanning headlines. InvestorPlace analysts focus on long-term themes, market timing, and structural shifts shaping where capital is flowing next, highlighting stocks positioned to benefit from those trends.

Nvidia Stock Looks Overvalued, But Shares Remain A Cautious Buy

By Thomas Niel, InvestorPlace Contributor
Yet, considering shares have moved too far, too fast, those looking for a long-term position may want to take a "wait-and-see" approach. Bottom line: don't bet the ranch, but NVDA stock remains a cautious near-term buy.

Keytruda Powers a Stellar Q2 for Merck

By Muslim Farooque, InvestorPlace Contributor
Massive sales from the ever-so dependable Keytruda in the second quarter and aggressive actions make MRK stock a fabulous investment.

MGM Resorts May Have Just Enough Liquidity to Survive

By Mark R. Hake, CFA
MGM stock is worth 3.5 times more, but because its liquidity is so tight right now, the road to those gains will be rocky.

The Experts Have No Clue How Cheap Amazon Stock Really Is

By Nicolas Chahine, InvestorPlace Contributor
AMZN stock is cheap, but few experts say that. Amazon has shattered growth expectations for decades, so it's time to become a believer.

The Breakout Rally In Advanced Micro Devices Stock Is Far From Over

By InvestorPlace Research Staff
After doubling from the lows, AMD stock might seem to need a breather. But a secular growth story and a competitive edge suggest more upside ahead.

Workhorse Is a Promising EV and Drone Investment

By David Moadel, InvestorPlace Contributor
Who knew that last-mile delivery could be so exciting and lucrative? Take a different angle on electric vehicles with WKHS stock.

3 Reasons Why Logitech’s Stock Will Continue Marching Higher

By InvestorPlace Research Staff
With all the chaos that’s occurring because of the novel coronavirus, Logitech has been a source of consistent growth. Here are three reasons why LOGI stock will likely continue this run.

Bristol-Myers Squibb Is a Dirt-Cheap Buy Before Earnings

By David Moadel, InvestorPlace Contributor
Thanks to its Celgene acquisition, Bristol-Myers Squibb looks attractive ahead of earnings. Here's why you should buy BMY stock.

9 Boring Stocks to Buy You Should Never Let Go Of

By Josh Enomoto, InvestorPlace Contributor
These nine boring stocks to buy won’t elicit much excitement from the crowd, but they’re worthy contenders as we head toward an uncertain future.

Virgin Galactic Earnings Highlight Potential and Shortcomings

By Bret Kenwell, InvestorPlace Contributor
Virgin Galactic just reported earnings and they were near what investors expected. However, SPCE stock is declining as a result. Now what?

The Consumer Comeback in China Bodes Well for Alibaba Stock

By David Moadel, InvestorPlace Contributor
Consumer preferences are shifting in China, but that's not necessarily a bad thing for the owners of Alibaba stock.

At These Prices, It’s Time To Take a Chance on Low-Flying JetBlue Stock

By David Moadel, InvestorPlace Contributor
Analysts posted dismal projections for JetBlue yet the company underperformed anyway. But could JBLU stock be a surprise winner now?

Buffett Favorite Bank of America Stock Is Just Too Cheap to Ignore

By David Moadel, InvestorPlace Contributor
Multi-billionaire Warren Buffett just added to his position in BAC stock. Perhaps it's time for you to consider buying some shares as well.

Carnival Stock Has Smooth Seas in Its Future

By Mark R. Hake, CFA
Carnival is struggling, but it will do well in the long run. Expect CCL stock to soar to three or four times its current price.

Crocs’ Earnings Were Good, So Buy the Dip in CROX Stock

By Luke Lango, InvestorPlace Senior Investment Analyst
Crocs is the next big footwear brand, with huge long-term growth potential. Buy CROX stock on any near-term dips.

The Blue Apron Growth Inflection Is Here, So Buy APRN Stock

By Luke Lango, InvestorPlace Senior Investment Analyst
APRN stock is a misunderstood and undervalued asset with explosive upside potential if just a few things go right.

Nvidia’s Story Still Intact, But Be Cautious

By Todd Shriber, InvestorPlace Contributor
Nvidia is rumored to be considering a major acquisition, but the numbers indicate NVDA stock can deliver growth without a big deal.

Bristol-Myers Squibb Has Great Potential Ahead of Earnings

By Mark R. Hake, CFA
Ahead earnings, Bristol-Myers Squibb is a great value play. In fact, BMY stock is worth 30%-70% more than its current share price.

Stick With Plug Power for Long-Term Gains

By Luke Lango, InvestorPlace Senior Investment Analyst
Plug Power is selling the right solution at the right time, a simple reality which makes PLUG stock a buy on near-term dips.
Load More Articles